Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Bladder cancer stage III
ADR ID BADD_A09555
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.08      Renal and urinary tract neoplasms malignant and unspecified
16.08.01      Bladder neoplasms malignant
16.08.01.006      Bladder cancer stage III
20      Renal and urinary disorders
20.03      Bladder and bladder neck disorders (excl calculi)
20.03.04      Bladder neoplasms
20.03.04.009      Bladder cancer stage III
Description Not Available
MedDRA Code 10005011
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bladder cancer stage III | Bladder carcinoma stage III | Ca bladder stage III | Carcinoma bladder stage III | Carcinoma urinary bladder stage III | Invasive bladder cancer stage III | Malignant neoplasm of anterior wall of urinary bladder stage III | Malignant neoplasm of bladder neck stage III | Malignant neoplasm of bladder stage III | Malignant neoplasm of bladder, part unspecified stage III | Malignant neoplasm of dome of urinary bladder stage III | Malignant neoplasm of lateral wall of urinary bladder stage III | Malignant neoplasm of other specified sites of bladder stage III | Malignant neoplasm of posterior wall of urinary bladder stage III | Malignant neoplasm of trigone of urinary bladder stage III | Malignant neoplasm of urachus stage III | Malignant neoplasm of ureteric orifice stage III | Urinary bladder carcinoma stage III
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01913Ranitidine0.000038%
The 1th Page    1    Total 1 Pages